Seratrodast
Seratrodast
Seratrodast (pronounced: seh-rah-troh-dast) is a pharmacological agent used primarily in the treatment of asthma. It is classified as a Thromboxane A2 receptor antagonist, which means it works by inhibiting the action of Thromboxane A2, a substance in the body that causes narrowing of the airways and inflammation.
Etymology
The term "Seratrodast" is derived from the pharmaceutical nomenclature, where "sera" could be a reference to serum or blood, and "trodast" is likely a coined term specific to this drug. The exact etymology is not known as it is a proprietary name given by the drug's manufacturer.
Usage
Seratrodast is used to prevent and treat the symptoms of asthma. It is not used to relieve sudden attacks of asthma and therefore should not be used for an asthma attack that has already started.
Related Terms
- Thromboxane A2: A type of fat molecule involved in several biological processes, including inflammation and vasoconstriction. It is the target of Seratrodast.
- Thromboxane A2 receptor antagonist: A class of drugs that block the action of Thromboxane A2.
- Asthma: A chronic disease of the airways that makes breathing difficult. It is the primary condition treated with Seratrodast.
See Also
External links
- Medical encyclopedia article on Seratrodast
- Wikipedia's article - Seratrodast
This WikiMD article is a stub. You can help make it a full article.
Languages: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
Urdu,
বাংলা,
తెలుగు,
தமிழ்,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
European
español,
Deutsch,
français,
русский,
português do Brasil,
Italian,
polski